tranexamic acid has been researched along with Aphasia in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendelow, AD | 1 |
| Stockdill, G | 1 |
| Steers, AJ | 1 |
| Hayes, J | 1 |
| Gillingham, FJ | 1 |
1 trial available for tranexamic acid and Aphasia
| Article | Year |
|---|---|
Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage.
Topics: Angiography; Aphasia; Aspirin; Double-Blind Method; Female; Hemiplegia; Humans; Intracranial Aneurys | 1982 |